Abstract: Scleritine is used as a protective agent for cells against toxic agents, in particular chemical or physical agents. One or more embodiments relate to a dermatological and/or cosmetic composition, which protects the skin against toxic agents, characterized in that it comprises Scleritine in at least one excipient or vehicle adapted to a topical application. One or more embodiments concerns the pharmaceutical or cosmetic industry and more specifically the formulation of pharmaceutical or cosmetic compositions intended to protect cells against toxic agents.
Type:
Grant
Filed:
September 11, 2018
Date of Patent:
May 9, 2023
Assignees:
CENTRE SCIENTIFIQUE DE MONACO, CORALIOTECH